This actually reminds me quite a bit of the Abthrax situation with Human Genome Sciences and the US DoD. Because of the anthrax scare following 9/11, there was an urgent need of sorts. But the commercial viability of the drug wasn't all that meaningful to HGSI's prospects.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.